Transplantation for liver tumors: current status

Area of Science:

• Hepatobiliary oncology
• Transplantation surgery
• Cancer research

Background:

• Liver transplantation for hepatobiliary malignancy remains a topic of debate.
• Evidence from single-center studies and large databases supports its efficacy.
• Patient selection and tumor characteristics are crucial for successful outcomes.

Purpose of the Study:

• To evaluate the role and indications of liver transplantation for hepatobiliary malignancy.
• To identify factors influencing patient survival after liver transplantation for cancer.
• To explore future directions for improving treatment strategies.

Main Methods:

• Review of single-center studies and analysis of large patient databases.
• Evaluation of patient selection criteria, tumor type, and stage.
• Discussion of tumor biology, cancer prevention, early detection, and multimodal therapies.

Main Results:

• Liver transplantation is indicated for selected patients with hepatobiliary malignancy.
• Appropriate patient selection and favorable tumor type/stage are key predictors of success.
• Current evidence supports the benefit of liver replacement in specific cases.

Conclusions:

• Liver transplantation is a viable option for select patients with hepatobiliary cancers.
• Improved understanding of tumor biology and advanced treatment strategies are essential.
• Future efforts should focus on enhanced cancer prevention, early detection, and multimodal approaches to prolong survival.